Artigos de revistas sobre o tema "Les Mutations"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Les Mutations".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Tarlock, Katherine, Todd M. Cooper, Todd A. Alonzo, Robert Gerbing, Jessica Pollard, Richard Aplenc, E. Anders Kolb, Alan S. Gamis e Soheil Meshinchi. "Mutational Concordance from Diagnosis and Relapse in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group". Blood 128, n.º 22 (2 de dezembro de 2016): 2846. http://dx.doi.org/10.1182/blood.v128.22.2846.2846.
Texto completo da fonteGARCÍA-DORADO, A., C. LÓPEZ-FANJUL e A. CABALLERO. "Properties of spontaneous mutations affecting quantitative traits". Genetical Research 74, n.º 3 (dezembro de 1999): 341–50. http://dx.doi.org/10.1017/s0016672399004206.
Texto completo da fonteWatters, M. K., e D. R. Stadler. "Spontaneous mutation during the sexual cycle of Neurospora crassa." Genetics 139, n.º 1 (1 de janeiro de 1995): 137–45. http://dx.doi.org/10.1093/genetics/139.1.137.
Texto completo da fonteEllis, Nathan A. "Mutation-causing mutations". Nature 381, n.º 6578 (maio de 1996): 110–11. http://dx.doi.org/10.1038/381110a0.
Texto completo da fontePawlik, Timothy M., Darrell R. Borger, Yuhree Kim, David Cosgrove, Sorin Alexandrescu, Ryan Thomas Groeschl, Vikram Deshpande et al. "Genomic profiling of intrahepatic cholangiocarcinoma: Refining prognostic determinants and identifying therapeutic targets." Journal of Clinical Oncology 32, n.º 3_suppl (20 de janeiro de 2014): 210. http://dx.doi.org/10.1200/jco.2014.32.3_suppl.210.
Texto completo da fonteKang, S., S. S. Seo, H. J. Chang, C. W. Yoo, S. Y. Park e S. M. Dong. "Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma". International Journal of Gynecologic Cancer 18, n.º 6 (2008): 1339–43. http://dx.doi.org/10.1111/j.1525-1438.2007.01172.x.
Texto completo da fonteChao, Mwe, Kathrin Thomay, Gudrun Goehring, Marcin Wlodarski, Victor Pastor, Brigitte Schlegelberger, Detlev Schindler, Christian Kratz e Charlotte Niemeyer. "Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms". Klinische Pädiatrie 229, n.º 06 (novembro de 2017): 329–34. http://dx.doi.org/10.1055/s-0043-117046.
Texto completo da fonteHughes, Timothy, Giuseppe Saglio, Giovanni Martinelli, Dong-Wook Kim, S. Soverini, Martin Mueller, A. Haque et al. "Responses and Disease Progression in CML-CP Patients Treated with Nilotinib after Imatinib Failure Appear To Be Affected by the BCR-ABL Mutation Status and Types." Blood 110, n.º 11 (16 de novembro de 2007): 320. http://dx.doi.org/10.1182/blood.v110.11.320.320.
Texto completo da fontePálinkás, Hajnalka Laura, Lőrinc Pongor, Máté Balajti, Ádám Nagy, Kinga Nagy, Angéla Békési, Giampaolo Bianchini, Beáta G. Vértessy e Balázs Győrffy. "Primary Founder Mutations in the PRKDC Gene Increase Tumor Mutation Load in Colorectal Cancer". International Journal of Molecular Sciences 23, n.º 2 (6 de janeiro de 2022): 633. http://dx.doi.org/10.3390/ijms23020633.
Texto completo da fonteAhn, TaeJin, e Taesung Park. "Pathway-Driven Discovery of Rare Mutational Impact on Cancer". BioMed Research International 2014 (2014): 1–10. http://dx.doi.org/10.1155/2014/171892.
Texto completo da fonteRobinson, Philip S., Tim H. H. Coorens, Claire Palles, Emily Mitchell, Federico Abascal, Sigurgeir Olafsson, Bernard C. H. Lee et al. "Increased somatic mutation burdens in normal human cells due to defective DNA polymerases". Nature Genetics 53, n.º 10 (30 de setembro de 2021): 1434–42. http://dx.doi.org/10.1038/s41588-021-00930-y.
Texto completo da fonteMachado, Heather E., Nina Friesgaard Øbro, Emily Mitchell, Megan Davies, Anthony R. Green, Kourosh Saeb-Parsy, Daniel James Hodson, David Kent e Peter J. Campbell. "Life History of Normal Human Lymphocytes Revealed By Somatic Mutations". Blood 134, Supplement_1 (13 de novembro de 2019): 1045. http://dx.doi.org/10.1182/blood-2019-128188.
Texto completo da fonteAhn, Jae-Sook, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, Il-Kwon Lee, Nan Young Kim, Mark D. Minden, Chul Won Jung et al. "An Adverse Prognostic Effect of Homozygous TET2 Mutational Status on the Relapse Risk of Acute Myeloid Leukemia Patients of Normal Karyotype". Blood 124, n.º 21 (6 de dezembro de 2014): 1052. http://dx.doi.org/10.1182/blood.v124.21.1052.1052.
Texto completo da fonteKustova, D. V., E. V. Motyko, A. N. Kirienko, T. N. Gert, I. V. Leppyanen, M. P. Bakay, E. V. Efremova et al. "Retrospective analysis of own long-term experience in studying the BCR::ABL kinase domain mutational status in patients with chronic myeloid leukemia". Oncohematology 19, n.º 3 (1 de setembro de 2024): 45–60. http://dx.doi.org/10.17650/1818-8346-2024-19-3-45-60.
Texto completo da fonteWayne, Marta L., e Trudy F. C. Mackay. "Quantitative Genetics of Ovariole Number in Drosophila melanogaster. II. Mutational Variation and Genotype-Environment Interaction". Genetics 148, n.º 1 (1 de janeiro de 1998): 201–10. http://dx.doi.org/10.1093/genetics/148.1.201.
Texto completo da fonteJeffers, Michael, Christian Kappeler, Iris Kuss, Georg Beckmann, Daniel H. Mehnert, Johannes Fredebohm e Michael Teufel. "Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal stromal tumor (GIST): correlative analysis from the GRID trial". Gastric Cancer 25, n.º 3 (20 de janeiro de 2022): 598–608. http://dx.doi.org/10.1007/s10120-021-01274-6.
Texto completo da fonteGolding, G. Brian, Patricia J. Gearhart e Barry W. Glickman. "Patterns of Somatic Mutations in Immunoglobulin Variable Genes". Genetics 115, n.º 1 (1 de janeiro de 1987): 169–76. http://dx.doi.org/10.1093/genetics/115.1.169.
Texto completo da fonteShang, Yanhong, Hao Zhang, Aiming Zang, Shaohua Yuan, Xiaofang Li, Wenpan Zhang, Ran Huo et al. "Abstract 5754: The molecular characteristics of EGFR co-mutations in lung adenocarcinoma". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 5754. http://dx.doi.org/10.1158/1538-7445.am2022-5754.
Texto completo da fonteLee, Ye Ji, Yejin Lee, Youn Jung Kim, Zang Hee Lee e Jung-Wook Kim. "Novel PAX9 Mutations Causing Isolated Oligodontia". Journal of Personalized Medicine 14, n.º 2 (8 de fevereiro de 2024): 191. http://dx.doi.org/10.3390/jpm14020191.
Texto completo da fonteXu, Fan, Qingshan Li, Wenxin LI, Shenglin Zhang, Yaping Zhao, Didi Guo, Zhongyu Lu et al. "Molecular characteristics of ERBB2-activating mutations in Chinese patients with NSCLC." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): 8546. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.8546.
Texto completo da fonteWang, Yan, Fei Ran, Jin Lin, Jing Zhang e Dan Ma. "Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL". Technology in Cancer Research & Treatment 22 (janeiro de 2023): 153303382311540. http://dx.doi.org/10.1177/15330338231154092.
Texto completo da fonteKapoor, Ritika R., Sarah E. Flanagan, Piers Fulton, Anupam Chakrapani, Bernadette Chadefaux, Tawfeg Ben-Omran, Indraneel Banerjee, Julian P. Shield, Sian Ellard e Khalid Hussain. "Hyperinsulinism–hyperammonaemia syndrome: novel mutations in the GLUD1 gene and genotype–phenotype correlations". European Journal of Endocrinology 161, n.º 5 (novembro de 2009): 731–35. http://dx.doi.org/10.1530/eje-09-0615.
Texto completo da fonteMoltara, Maja Ebert, Srdjan Novakovic, Marko Boc, Marina Bucic, Martina Rebersek, Vesna Zadnik e Janja Ocvirk. "Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma". Radiology and Oncology 52, n.º 3 (26 de abril de 2018): 289–95. http://dx.doi.org/10.2478/raon-2018-0017.
Texto completo da fonteYeo, Joshua Yi, Darius Wen-Shuo Koh, Ping Yap, Ghin-Ray Goh e Samuel Ken-En Gan. "Spontaneous Mutations in HIV-1 Gag, Protease, RT p66 in the First Replication Cycle and How They Appear: Insights from an In Vitro Assay on Mutation Rates and Types". International Journal of Molecular Sciences 22, n.º 1 (31 de dezembro de 2020): 370. http://dx.doi.org/10.3390/ijms22010370.
Texto completo da fonteBorowczyk, Martyna, Ewelina Szczepanek-Parulska, Szymon Dębicki, Bartłomiej Budny, Małgorzata Janicka-Jedyńska, Lidia Gil, Frederik A. Verburg et al. "High incidence of FLT3 mutations in follicular thyroid cancer: potential therapeutic target in patients with advanced disease stage". Therapeutic Advances in Medical Oncology 12 (janeiro de 2020): 175883592090753. http://dx.doi.org/10.1177/1758835920907534.
Texto completo da fonteThomas, Renjan, Gautam Balaram, Hrishi Varayathu, Suhas N. Ghorpade, Prarthana V. Kowsik, Baby Dharman, Beulah Elsa Thomas et al. "Molecular epidemiology and clinical characteristics of epidermal growth factor receptor mutations in NSCLC: A single-center experience from India". Journal of Cancer Research and Therapeutics 19, n.º 5 (2023): 1398–406. http://dx.doi.org/10.4103/jcrt.jcrt_1986_21.
Texto completo da fonteKeightley, Peter D., Esther K. Davies, Andrew D. Peters e Ruth G. Shaw. "Properties of Ethylmethane Sulfonate-Induced Mutations Affecting Life-History Traits in Caenorhabditis elegans and Inferences About Bivariate Distributions of Mutation Effects". Genetics 156, n.º 1 (1 de setembro de 2000): 143–54. http://dx.doi.org/10.1093/genetics/156.1.143.
Texto completo da fonteMaxwell, Kara Noelle, Daniel De Sloover, Lyndsey Emery, Bradley Wubbenhorst, Kurt P. D'Andrea, Jessica Long, Rebecca Mueller et al. "The mutational spectrum of breast and ovarian tumors from BRCA1 and BRCA2 mutation carriers." Journal of Clinical Oncology 31, n.º 15_suppl (20 de maio de 2013): 1510. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1510.
Texto completo da fonteDelaugerre, Constance, Mireille Mouroux, Anne Yvon-Groussin, Anne Simon, Francis Angleraud, Jean-Marie Huraux, Henri Agut, Christine Katlama e Vincent Calvez. "Prevalence and Conditions of Selection of E44D/A and V118I Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutations in Clinical Practice". Antimicrobial Agents and Chemotherapy 45, n.º 3 (1 de março de 2001): 946–48. http://dx.doi.org/10.1128/aac.45.3.946-948.2001.
Texto completo da fonteGu, Jin, Jianfei Yao, Lele Song, Dandan Huang, Zhaoya Gao, Qingkun Gao, Pengfei Niu et al. "The mutational landscape of the adjacent paracancerous tissues confirmed the safe margin of 2-5cm in colorectal cancer resection." Journal of Clinical Oncology 38, n.º 15_suppl (20 de maio de 2020): e16060-e16060. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e16060.
Texto completo da fonteLee, Peak-Ling, Benedict Yan, Chin-Hin Ng, Kenneth Hon-Kim Ban, Wee-Joo Chng e Evelyn Siew-Chuan Koay. "Characterization of AML Patients with CEBPA Mutations in a South-East Asian Population". Blood 126, n.º 23 (3 de dezembro de 2015): 2574. http://dx.doi.org/10.1182/blood.v126.23.2574.2574.
Texto completo da fonteSerapinas, Danielius, Marius Sukys, Agne Bartkeviciute, Diana Barkauskiene e Daiva Bartkeviciene. "The spectrum of the most common BRCA1/BRCA2 mutations in Lithuanian high risk families". Genetika 49, n.º 1 (2017): 43–50. http://dx.doi.org/10.2298/gensr1701043s.
Texto completo da fonteZeineddine, Fadl, Benjamin Garmezy, Timothy A. Yap e John Paul Y. C. Shen. "PMC: A more precise classifier of POLE mutations to identify candidates for immune therapy." Journal of Clinical Oncology 39, n.º 15_suppl (20 de maio de 2021): 3548. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.3548.
Texto completo da fonteTrindade, Sandra, Lilia Perfeito e Isabel Gordo. "Rate and effects of spontaneous mutations that affect fitness in mutator Escherichia coli". Philosophical Transactions of the Royal Society B: Biological Sciences 365, n.º 1544 (27 de abril de 2010): 1177–86. http://dx.doi.org/10.1098/rstb.2009.0287.
Texto completo da fonteOlafsson, S., R. E. McIntyre, T. Coorens, T. Butler, P. Robinson, H. Lee-Six, M. Sanders et al. "DOP50 The landscape of somatic mutations in non-neoplastic IBD-affected colon". Journal of Crohn's and Colitis 14, Supplement_1 (janeiro de 2020): S088—S089. http://dx.doi.org/10.1093/ecco-jcc/jjz203.089.
Texto completo da fonteDong, Chao, Hushan Zhang, Weiqing Liu, Deyu Kong, Xiao Chen, Fei Mo, Jun Deng e Ying Qian. "Postoperative prognosis in patients with NSCLC with different EGFR mutation sites." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junho de 2023): e20528-e20528. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e20528.
Texto completo da fonteHu, Zishuo Ian, Anna M. Varghese, Jinru Shia, Alice Zervoudakis, Maeve Aine Lowery, Kenneth H. Yu, Sree Bhavani Chalasani et al. "Clinical characterization of pancreatic ductal adenocarcinomas (PDAC) with mismatch repair (MMR) gene mutations." Journal of Clinical Oncology 35, n.º 15_suppl (20 de maio de 2017): e15791-e15791. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e15791.
Texto completo da fonteWille, Sandra, Vera Grossmann, Tamara Alpermann, Claudia Haferlach, Wolfgang Kern, Susanne Schnittger, Torsten Haferlach e Alexander Kohlmann. "Landscape of TET2 Mutations In Acute Myeloid Leukemia (AML): A Next-Generation Sequencing Study Investigating 76 Cases Comprehensively Characterized for Cytogenetics and Other Molecular Markers." Blood 116, n.º 21 (19 de novembro de 2010): 1035. http://dx.doi.org/10.1182/blood.v116.21.1035.1035.
Texto completo da fonteSong, Hao, Yao Huang e Xiaoqing Jiang. "Mutation spectrum associated with metastasis of advanced cholangiocarcinoma". Journal of International Medical Research 50, n.º 6 (junho de 2022): 030006052211020. http://dx.doi.org/10.1177/03000605221102080.
Texto completo da fonteKim, Youn Jung, Hong Zhang, Yejin Lee, Figen Seymen, Mine Koruyucu, Yelda Kasimoglu, James P. Simmer, Jan C. C. Hu e Jung-Wook Kim. "Novel WDR72 Mutations Causing Hypomaturation Amelogenesis Imperfecta". Journal of Personalized Medicine 13, n.º 2 (14 de fevereiro de 2023): 326. http://dx.doi.org/10.3390/jpm13020326.
Texto completo da fonteClaes, Kathleen, Eva Machackova, Michel De Vos, Bruce Poppe, Anne De Paepe e Ludwine Messiaen. "Mutation Analysis of the BRCA1 and BRCA2 Genes in the Belgian Patient Population and Identification of a Belgian Founder Mutation BRCA1 IVS5+3A>G". Disease Markers 15, n.º 1-3 (1999): 69–73. http://dx.doi.org/10.1155/1999/241046.
Texto completo da fonteLin, Ming-En, Hsin-An Hou, Yuan-Yeh Kuo, Wen-Chien Chou, Ming Cheng Lee, Chien-Yuan Chen, Yan-Jun Lai et al. "DNMT3A mutations in De Novo Myelodysplastic Syndrome: Distinct Clinico-Biological Features and Prognostic Relevance". Blood 120, n.º 21 (16 de novembro de 2012): 3799. http://dx.doi.org/10.1182/blood.v120.21.3799.3799.
Texto completo da fonteSwierczek, Sabina, Christine Bellanne-Chantelot, Donghoon Yoon, Cecile Saint-Martin, Soo Jin Kim, Albert Najman e Josef T. Prchal. "TET2 Mutations in Polycythemia Vera (PV) in Some Cases Follow Rather Than Precede JAK2 V617F Mutation, Are Not a Disease-Initiating Event, Affect Mainly Erythropoiesis, and Contribute to Increased Aggressivity of PV Clone." Blood 114, n.º 22 (20 de novembro de 2009): 3913. http://dx.doi.org/10.1182/blood.v114.22.3913.3913.
Texto completo da fonteJuriloff, D. M., S. D. Porter e M. J. Harris. "Three spontaneous mutations at the albino locus in SELH/Bc mice". Genome 37, n.º 2 (1 de abril de 1994): 190–97. http://dx.doi.org/10.1139/g94-026.
Texto completo da fonteAlohali, Sama, Alexandra E. Payne, Marc Pusztaszeri, Mohannad Rajab, Véronique-Isabelle Forest, Michael P. Hier, Michael Tamilia e Richard J. Payne. "Effect of Having Concurrent Mutations on the Degree of Aggressiveness in Patients with Thyroid Cancer Positive for TERT Promoter Mutations". Cancers 15, n.º 2 (8 de janeiro de 2023): 413. http://dx.doi.org/10.3390/cancers15020413.
Texto completo da fonteAbdel-Wahab, Omar, Animesh Pardanani, Jay Patel, Terra Lasho, Adriana Heguy, Ross Levine e Ayalew Tefferi. "Concomitant Analysis of EZH2 and ASXL1 Mutations In Myelofibrosis, Chronic Myelomonocytic Leukemia and Blast-Phase Myeloproliferative Neoplasms". Blood 116, n.º 21 (19 de novembro de 2010): 3070. http://dx.doi.org/10.1182/blood.v116.21.3070.3070.
Texto completo da fonteHeinrich, Michael C., Christopher L. Corless, George D. Demetri, Charles D. Blanke, Margaret von Mehren, Heikki Joensuu, Laura S. McGreevey et al. "Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor". Journal of Clinical Oncology 21, n.º 23 (1 de dezembro de 2003): 4342–49. http://dx.doi.org/10.1200/jco.2003.04.190.
Texto completo da fonteHeinrich, Michael C., Christopher L. Corless, George D. Demetri, Charles D. Blanke, Margaret von Mehren, Heikki Joensuu, Laura S. McGreevey et al. "Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor". Journal of Clinical Oncology 41, n.º 31 (1 de novembro de 2023): 4829–36. http://dx.doi.org/10.1200/jco.22.02771.
Texto completo da fonteRies, Rhonda E., Xiaotu Ma, Claudia Tregnago, Todd A. Alonzo, Jim Wang, Tiffany Hylkema, Benjamin J. Huang et al. "DNMT3A Mutants Are Enriched in NPMc+ AML and Associated with Adverse Outcome in Childhood AML". Blood 142, Supplement 1 (28 de novembro de 2023): 4306. http://dx.doi.org/10.1182/blood-2023-181060.
Texto completo da fonteDufour, Annika, Stefan K. Bohlander, Evelyn Zellmeier, Gudrun Mellert, Karsten Spiekermann, Stephanie Schneider, Purvi Kakadia et al. "Disruption of TP53 function by Point Mutations and Deletions Is Associated with An Increased Risk of Disease Progression within Previously Treated, Relapsed Chronic Lymphocytic Leukemia Patients". Blood 118, n.º 21 (18 de novembro de 2011): 2445. http://dx.doi.org/10.1182/blood.v118.21.2445.2445.
Texto completo da fonte